CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that it has renewed its contract with the Transfusion Service of the Swiss Red Cross (Blutspende SRK Schweiz) by entering into a five-year purchase agreement for the INTERCEPT Blood System for platelets.
Help employers find you! Check out all the jobs and post your resume.